Nephros, Inc. Posts Updated 2026 Corporate Presentation

Nephros, Inc. filed a Form 8-K on June 12, 2026, to disclose that the company posted an updated 2026 Corporate Presentation on its corporate website. The filing, submitted under Item 7.01 (Regulation FD Disclosure), includes the presentation as Exhibit 99.1. The company specifically notes that this information is being "furnished" rather than "filed" under SEC rules, meaning it is not subject to liability under Section 18 of the Exchange Act and will not be deemed incorporated by reference in other filings unless specifically referenced. The filing was signed by Judy Krandel, Chief Financial Officer, and includes the required cover page interactive data file. This is a routine disclosure of corporate materials to investors and the public through the company's website.